Detalhe da pesquisa
1.
MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.
Support Care Cancer
; 30(6): 4711-4728, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274188
2.
MASCC recommendations on the management of constipation in patients with advanced cancer.
Support Care Cancer
; 28(1): 23-33, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396746
3.
Response to Cleary et al. re MASCC evidence-based recommendations for the management of malignant bowel obstruction.
Support Care Cancer
; 30(10): 7825-7826, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902407
4.
Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability.
BMC Palliat Care
; 16(1): 22, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28335763
5.
Complexity in non-pharmacological caregiving activities at the end of life: an international qualitative study.
PLoS Med
; 9(2): e1001173, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22347815
6.
New analgesics in cancer pain.
Curr Opin Support Palliat Care
; 16(2): 60-64, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639570
7.
The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured review.
PLoS One
; 13(3): e0194236, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29538455
8.
Updates in palliative care - overview and recent advancements in the pharmacological management of cancer pain.
Clin Med (Lond)
; 18(1): 17-22, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29436434
9.
Anticipatory syringe pumps: benefits and risks.
BMJ Support Palliat Care
; 11(3): 303-304, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468505
10.
Use and practice implications of modified-release medicines.
Nurs Times
; 101(50): 21-2, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16379444
11.
Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion.
J Palliat Med
; 16(1): 38-43, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23234300
12.
Letter to the Editor re 'Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer (BMJ Support Palliat Care 2016;6:344-52)'.
BMJ Support Palliat Care
; 7(3): 264, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27965212
13.
Integrated strategies for the successful management of breakthrough cancer pain.
Curr Opin Support Palliat Care
; 5(1): 8-14, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21325998
14.
Incorrect Use of the English Language Term "Episodic".
J Pain Symptom Manage
; 52(5): e1, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401518
15.
Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis.
Clin J Pain
; 27(7): 623-30, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21610491
16.
Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain.
J Pain Symptom Manage
; 26(6): 1073-4, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14654258
17.
The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.
Eur J Pain
; 13(4): 331-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18707904
18.
NSAIDs: gastroprotection or selective COX-2 inhibitor?
Palliat Med
; 18(4): 275-86, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15198117
19.
Breakthrough cancer pain.
BMJ
; 337: a2689, 2008 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19033342
20.
Use of nebulised adrenaline in the management of steroid-resistant stridor.
Palliat Med
; 21(8): 723-4, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18073262